ea0063p247 | Pituitary and Neuroendocrinology 1 | ECE2019
, Barchetti Giovanni
, Grunenwald Solange
, Bonneville Fabrice
, Caron Philippe
Introduction: Primary SMSa treatment can be associated with hormonal remission and tumor shrinkage in patients with GH-secreting pituitary adenomas. In the 2014 Endocrine Society guideline for Acromegaly, there is no specific mention of MRI follow-up during long-term SMSa treatment. The aim of this study was to evaluate any change of GH-secreting adenoma size during primary SMSa treatment and whether regular MRI follow-up was necessary in acromegalic patients treated with firs...